|
|
|
|
|
HOME >
CORPORATE INFO > CORPORATE ANNOUNCEMENTS
|
|
|
|
|
|
15-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange about Transcript |
|
|
|
|
|
11-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication |
|
|
|
|
|
10-05-2024
|
|
|
|
| DR. LAL PATH LABS LTD. has informed the Exchange regarding Allotment of Securities |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange about Link of Recording |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Mrs Vandana Lal as Executive Director of the company w.e.f. April 01, 2025. |
|
|
|
|
|
10-05-2024
|
|
|
|
| DR. LAL PATH LABS LTD. has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange that Board of Directors at its meeting held on May 10, 2024, recommended Final Dividend of 6 per equity share. |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding Allotment of 2500 Shares under ESOP Plan 2010 |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding Grant of 18000 Options. |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has submitted to the Exchange, the financial results for the period ended March 31, 2024. |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange about Investor Presentation |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding Board meeting held on May 10, 2024. |
|
|
|
|
|
10-05-2024
|
|
|
|
| DR. LAL PATH LABS LTD. has informed the Exchange regarding Outcome of Board Meeting held on 10-May-2024 for Dividend |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated May 10, 2024, titled "Press Release on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024". |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange that Record date for the purpose of Dividend is 10-Jun-2024. |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding 'Convening of 30th Annual General Meeting (AGM) of the Company on Saturday, June 29, 2024, through Video Conferencing/ Other Audio-Visual Means (VC/OVAM).'. |
|
|
|
|
|
10-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange regarding 'Re-appointment of M/s Ernst & Young LLP (EY) as the Internal Auditors of the Company for the Financial Year 2024-25 and Re-appointment of M/s A.G. Agarwal & Associates as the Cost Auditors of the |
|
|
|
|
|
03-05-2024
|
|
|
|
| Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet |
|
|
|
|
|
03-05-2024
|
|
|
|
| DR. LAL PATH LABS LTD. has informed the Exchange about Board Meeting to be held on 10-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Other business. |
|
|
|
|
|
03-05-2024
|
|
|
|
| DR. LAL PATH LABS LTD. has informed the Exchange about Closure of Trading Window |
|
|
|
|
|
|
|
|
|
|
|
|